Men's Hormone Health and TRT in Scottsdale

Testosterone deficiency, also called hypogonadism in appropriate clinical contexts, involves compatible symptoms or signs and consistently low testosterone due to a problem affecting testicular or hormonal function. Aging alone or a single low result does not establish the diagnosis. The cause matters because treatment, fertility implications, and the need for additional evaluation can differ.

The Endocrine Society's testosterone therapy guideline resources recommend diagnosis only in men with consistent symptoms or signs and unequivocally and consistently low serum testosterone concentrations, using accurate testing and repeat confirmation.

Men may seek evaluation for reduced libido, sexual concerns, reduced spontaneous erections, loss of body hair, low bone density, anemia, reduced muscle mass, fatigue, mood changes, or other concerns. Many of these are nonspecific. Sleep apnea, depression, medication effects, obesity, diabetes, thyroid disease, chronic illness, alcohol use, relationship factors, and normal aging can overlap.

The webpage should not tell a reader that symptoms mean "low T." The physician's task is to determine whether testosterone is relevant and whether another cause needs treatment.

An evaluation may fit adult men with persistent compatible symptoms, a prior low result that needs confirmation, a medical condition or treatment associated with hypogonadism, or questions about an existing testosterone prescription. It may also be appropriate for men who want fertility implications or monitoring reviewed before continuing therapy.

TRT may be inappropriate or require specialist input in certain situations.

1. Confirm that the practice offers the needed evaluation and explain fees and policy.
2. Complete secure history and provide prior laboratory and treatment records.
3. Meet with a physician for symptom, fertility, risk, and medication review.
4. Obtain appropriately timed confirmatory testing when indicated.
5. Evaluate the possible cause and whether referral is needed.
6. Discuss treatment and non-treatment options.

7.

The intended approach is medically appropriate restraint. Testosterone should not be prescribed simply to pursue a higher number, athletic performance, or generalized vitality. The physician should define the diagnosis, the symptoms treatment is intended to address, the expected timeframe for reassessment, and the reasons to adjust or stop.

FDA product labeling continues to matter. In February 2025, the FDA announced class-wide labeling changes, including changes related to cardiovascular risk language and blood-pressure warnings based on updated evidence. This does not make treatment risk-free or appropriate without diagnosis and monitoring.

• Symptoms alone do not diagnose testosterone deficiency.
• A single low result may be misleading and generally requires appropriate confirmation.
• TRT can suppress sperm production and affect fertility.
• Treatment can cause side effects and requires monitoring.
• Blood pressure and product-specific warnings should be reviewed.
• Some men need evaluation for sleep apnea, pituitary disease, medication effects, obesity, or another cause.
• Treatment should be reassessed when symptoms do not improve or risk changes.

• Endocrine Society testosterone therapy guideline resources
• Endocrine Society 2026 statement on testosterone replacement therapy
• FDA class-wide labeling changes for testosterone products
• FDA Testosterone Information

This page is general education and does not diagnose testosterone deficiency or recommend TRT. Do not start, stop, or change prescribed testosterone without guidance from the treating clinician.